Out-licensing

Cripto-1 expression increases the expression of TNF-alpha in CD4+ T cells in tissues affected by chronic inflammatory disease. More

Cancer immunotherapy using dendritic cells, and iii) Camel recombinant antibodies for FoxP3, Mucl & CEA. More

Proprietary supercritical fluid (SCF) technology to improve bioavailability, enhance stability and optimise drug delivery for small and large molecules in a range of dosage forms More

immuno-suppresant agent More

Enhancing the dissolution performance of small and large molecules in a range of dosage forms More

Increasing the stability and improving the reconstitution of biomolecules using supercritical fluid (SCF) processing More

Crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More

An ELISA using chimeric peptides for early diagnosis of rheumatoid arthritis. Tested in sera from 900 patients, it shows improved sensitivity and prognostic value, as it identified patients with aggressive disease and worked where other tests failed More